|
Carrilero B, Murcia L, Martínez-Lage L, Segovia M. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country. Rev Esp Quimioter. 2011 Sep;24(3):123-6. PubMed PMID: 21947093.
AÑO: 2011; IF: 0.81
|
21947093
|
Alonso F, Giménez Font P, Manchón M, Ruiz de Ybáñez R, Segovia M, Berriatua E. Geographical variation and factors associated to seroprevalence of canine leishmaniosis in an endemic Mediterranean area. Zoonoses Public Health. 2010 Aug;57(5):318-28. doi: 10.1111/j.1863-2378.2008.01228.x. PubMed PMID: 19486495.
AÑO: 2010; IF: 2.22
|
|
Murcia L, Carrilero B, Muñoz MJ, Iborra MA, Segovia M. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother. 2010 Aug;65(8):1759-64. doi: 10.1093/jac/dkq201. Epub 2010 Jun 11. PubMed PMID: 20542903.
AÑO: 2010; IF: 4.659
|
|
Ortiz G, Yagüe G, Segovia M, Catalán V. A study of air microbe levels in different areas of a hospital. Curr Microbiol. 2009 Jul;59(1):53-8. doi: 10.1007/s00284-009-9398-7. Epub 2009 Mar 28. PubMed PMID: 19330376.
AÑO: 2009; IF: 1.33
|
|
Carrilero B, Quesada JJ, Alfayate S, Segovia M. [Congenital Chagas disease in a newborn of a Bolivian mother]. Enferm Infecc Microbiol Clin. 2009 Oct;27(8):486-7. doi: 10.1016/j.eimc.2009.01.004. Epub 2009 May 5. Spanish. PubMed PMID: 19406526.
AÑO: 2009; IF: 1.393
|